位置:首页 > 蛋白库 > SYPM_HUMAN
SYPM_HUMAN
ID   SYPM_HUMAN              Reviewed;         475 AA.
AC   Q7L3T8; A8K0W4; Q9H6S5; Q9UFT1;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 156.
DE   RecName: Full=Probable proline--tRNA ligase, mitochondrial;
DE            EC=6.1.1.15;
DE   AltName: Full=Prolyl-tRNA synthetase;
DE            Short=ProRS;
DE   Flags: Precursor;
GN   Name=PARS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 67-475.
RC   TISSUE=Mammary cancer;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   INVOLVEMENT IN DEE75, AND VARIANT DEE75 LEU-279.
RX   PubMed=25629079; DOI=10.1002/mgg3.115;
RA   Sofou K., Kollberg G., Holmstroem M., Davila M., Darin N., Gustafsson C.M.,
RA   Holme E., Oldfors A., Tulinius M., Asin-Cayuela J.;
RT   "Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the
RT   mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in
RT   patients with Alpers syndrome.";
RL   Mol. Genet. Genomic Med. 3:59-68(2015).
RN   [8]
RP   INVOLVEMENT IN DEE75, AND VARIANTS DEE75 ILE-95 AND LYS-203.
RX   PubMed=28077841; DOI=10.1038/jhg.2016.163;
RA   Mizuguchi T., Nakashima M., Kato M., Yamada K., Okanishi T.,
RA   Ekhilevitch N., Mandel H., Eran A., Toyono M., Sawaishi Y., Motoi H.,
RA   Shiina M., Ogata K., Miyatake S., Miyake N., Saitsu H., Matsumoto N.;
RT   "PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.";
RL   J. Hum. Genet. 62:525-529(2017).
RN   [9]
RP   ERRATUM OF PUBMED:28077841.
RX   PubMed=28202951; DOI=10.1038/jhg.2017.13;
RA   Mizuguchi T., Nakashima M., Kato M., Yamada K., Okanishi T.,
RA   Ekhilevitch N., Mandel H., Eran A., Toyono M., Sawaishi Y., Motoi H.,
RA   Shiina M., Ogata K., Miyatake S., Miyake N., Saitsu H., Matsumoto N.;
RL   J. Hum. Genet. 62:587-587(2017).
RN   [10]
RP   INVOLVEMENT IN DEE75, AND VARIANTS DEE75 THR-80 AND ARG-364.
RX   PubMed=29410512; DOI=10.1038/s10038-017-0401-z;
RA   Ciara E., Rokicki D., Lazniewski M., Mierzewska H., Jurkiewicz E.,
RA   Bekiesinska-Figatowska M., Piekutowska-Abramczuk D., Iwanicka-Pronicka K.,
RA   Szymanska E., Stawinski P., Kosinska J., Pollak A., Pronicki M.,
RA   Plewczynski D., Ploski R., Pronicka E.;
RT   "Clinical and molecular characteristics of newly reported mitochondrial
RT   disease entity caused by biallelic PARS2 mutations.";
RL   J. Hum. Genet. 63:473-485(2018).
RN   [11]
RP   INVOLVEMENT IN DEE75, AND VARIANTS DEE75 ILE-95 AND GLY-202.
RX   PubMed=29915213; DOI=10.1038/s10038-018-0478-z;
RA   Yin X., Tang B., Mao X., Peng J., Zeng S., Wang Y., Jiang H., Li N.;
RT   "The genotypic and phenotypic spectrum of PARS2-related infantile-onset
RT   encephalopathy.";
RL   J. Hum. Genet. 63:971-980(2018).
RN   [12]
RP   VARIANT DEE75 ILE-95.
RX   PubMed=30237576; DOI=10.1038/s41436-018-0138-x;
RA   Maddirevula S., Alzahrani F., Al-Owain M., Al Muhaizea M.A., Kayyali H.R.,
RA   AlHashem A., Rahbeeni Z., Al-Otaibi M., Alzaidan H.I., Balobaid A.,
RA   El Khashab H.Y., Bubshait D.K., Faden M., Yamani S.A., Dabbagh O.,
RA   Al-Mureikhi M., Jasser A.A., Alsaif H.S., Alluhaydan I., Seidahmed M.Z.,
RA   Alabbasi B.H., Almogarri I., Kurdi W., Akleh H., Qari A., Al Tala S.M.,
RA   Alhomaidi S., Kentab A.Y., Salih M.A., Chedrawi A., Alameer S., Tabarki B.,
RA   Shamseldin H.E., Patel N., Ibrahim N., Abdulwahab F., Samira M., Goljan E.,
RA   Abouelhoda M., Meyer B.F., Hashem M., Shaheen R., AlShahwan S.,
RA   Alfadhel M., Ben-Omran T., Al-Qattan M.M., Monies D., Alkuraya F.S.;
RT   "Autozygome and high throughput confirmation of disease genes candidacy.";
RL   Genet. Med. 21:736-742(2019).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-proline + tRNA(Pro) = AMP + diphosphate + L-prolyl-
CC         tRNA(Pro); Xref=Rhea:RHEA:14305, Rhea:RHEA-COMP:9700, Rhea:RHEA-
CC         COMP:9702, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:60039,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78532, ChEBI:CHEBI:456215;
CC         EC=6.1.1.15;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305}.
CC   -!- DISEASE: Developmental and epileptic encephalopathy 75 (DEE75)
CC       [MIM:618437]: A form of epileptic encephalopathy, a heterogeneous group
CC       of severe early-onset epilepsies characterized by refractory seizures,
CC       neurodevelopmental impairment, and poor prognosis. Development is
CC       normal prior to seizure onset, after which cognitive and motor delays
CC       become apparent. DEE75 is an autosomal recessive form characterized by
CC       onset of severe refractory seizures in the first months of life.
CC       {ECO:0000269|PubMed:25629079, ECO:0000269|PubMed:28077841,
CC       ECO:0000269|PubMed:29410512, ECO:0000269|PubMed:29915213,
CC       ECO:0000269|PubMed:30237576}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15178.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK025585; BAB15178.1; ALT_INIT; mRNA.
DR   EMBL; AK289679; BAF82368.1; -; mRNA.
DR   EMBL; AL139244; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06669.1; -; Genomic_DNA.
DR   EMBL; BC007956; AAH07956.2; -; mRNA.
DR   EMBL; BC011758; AAH11758.2; -; mRNA.
DR   EMBL; AL117473; CAB55948.1; -; mRNA.
DR   CCDS; CCDS597.1; -.
DR   PIR; T17258; T17258.
DR   RefSeq; NP_689481.2; NM_152268.3.
DR   AlphaFoldDB; Q7L3T8; -.
DR   SMR; Q7L3T8; -.
DR   BioGRID; 117457; 42.
DR   IntAct; Q7L3T8; 11.
DR   MINT; Q7L3T8; -.
DR   STRING; 9606.ENSP00000360327; -.
DR   DrugBank; DB00172; Proline.
DR   iPTMnet; Q7L3T8; -.
DR   PhosphoSitePlus; Q7L3T8; -.
DR   BioMuta; PARS2; -.
DR   DMDM; 73919761; -.
DR   EPD; Q7L3T8; -.
DR   jPOST; Q7L3T8; -.
DR   MassIVE; Q7L3T8; -.
DR   MaxQB; Q7L3T8; -.
DR   PaxDb; Q7L3T8; -.
DR   PeptideAtlas; Q7L3T8; -.
DR   PRIDE; Q7L3T8; -.
DR   ProteomicsDB; 68772; -.
DR   Antibodypedia; 33219; 62 antibodies from 19 providers.
DR   DNASU; 25973; -.
DR   Ensembl; ENST00000371279.4; ENSP00000360327.3; ENSG00000162396.6.
DR   GeneID; 25973; -.
DR   KEGG; hsa:25973; -.
DR   MANE-Select; ENST00000371279.4; ENSP00000360327.3; NM_152268.4; NP_689481.2.
DR   UCSC; uc001cxy.4; human.
DR   CTD; 25973; -.
DR   DisGeNET; 25973; -.
DR   GeneCards; PARS2; -.
DR   HGNC; HGNC:30563; PARS2.
DR   HPA; ENSG00000162396; Low tissue specificity.
DR   MalaCards; PARS2; -.
DR   MIM; 612036; gene.
DR   MIM; 618437; phenotype.
DR   neXtProt; NX_Q7L3T8; -.
DR   OpenTargets; ENSG00000162396; -.
DR   Orphanet; 442835; Non-specific early-onset epileptic encephalopathy.
DR   PharmGKB; PA142671198; -.
DR   VEuPathDB; HostDB:ENSG00000162396; -.
DR   eggNOG; KOG2324; Eukaryota.
DR   GeneTree; ENSGT00390000010922; -.
DR   HOGENOM; CLU_016739_4_1_1; -.
DR   InParanoid; Q7L3T8; -.
DR   OMA; NCDYAAN; -.
DR   OrthoDB; 409116at2759; -.
DR   PhylomeDB; Q7L3T8; -.
DR   TreeFam; TF105607; -.
DR   PathwayCommons; Q7L3T8; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   SignaLink; Q7L3T8; -.
DR   BioGRID-ORCS; 25973; 353 hits in 1091 CRISPR screens.
DR   GenomeRNAi; 25973; -.
DR   Pharos; Q7L3T8; Tbio.
DR   PRO; PR:Q7L3T8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q7L3T8; protein.
DR   Bgee; ENSG00000162396; Expressed in secondary oocyte and 139 other tissues.
DR   Genevisible; Q7L3T8; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IEA:UniProt.
DR   GO; GO:0004827; F:proline-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0006433; P:prolyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd00779; ProRS_core_prok; 1.
DR   Gene3D; 3.30.930.10; -; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   InterPro; IPR002314; aa-tRNA-synt_IIb.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR036621; Anticodon-bd_dom_sf.
DR   InterPro; IPR002316; Pro-tRNA-ligase_IIa.
DR   InterPro; IPR033730; ProRS_core_prok.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   Pfam; PF00587; tRNA-synt_2b; 1.
DR   PRINTS; PR01046; TRNASYNTHPRO.
DR   SUPFAM; SSF55681; SSF55681; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Disease variant; Epilepsy; Ligase;
KW   Mitochondrion; Nucleotide-binding; Protein biosynthesis;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..29
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..475
FT                   /note="Probable proline--tRNA ligase, mitochondrial"
FT                   /id="PRO_0000035818"
FT   VARIANT         28
FT                   /note="R -> S (in dbSNP:rs11577368)"
FT                   /id="VAR_052644"
FT   VARIANT         80
FT                   /note="I -> T (in DEE75; unknown pathological significance;
FT                   dbSNP:rs1246773873)"
FT                   /evidence="ECO:0000269|PubMed:29410512"
FT                   /id="VAR_082617"
FT   VARIANT         95
FT                   /note="V -> I (in DEE75; unknown pathological significance;
FT                   dbSNP:rs147227819)"
FT                   /evidence="ECO:0000269|PubMed:28077841,
FT                   ECO:0000269|PubMed:29915213, ECO:0000269|PubMed:30237576"
FT                   /id="VAR_082149"
FT   VARIANT         202
FT                   /note="R -> G (in DEE75; unknown pathological significance;
FT                   dbSNP:rs141760650)"
FT                   /evidence="ECO:0000269|PubMed:29915213"
FT                   /id="VAR_082618"
FT   VARIANT         203
FT                   /note="E -> K (in DEE75; unknown pathological significance;
FT                   dbSNP:rs1557762729)"
FT                   /evidence="ECO:0000269|PubMed:28077841"
FT                   /id="VAR_082619"
FT   VARIANT         235
FT                   /note="N -> S (in dbSNP:rs2270004)"
FT                   /id="VAR_034527"
FT   VARIANT         279
FT                   /note="S -> L (in DEE75; unknown pathological significance;
FT                   dbSNP:rs730882153)"
FT                   /evidence="ECO:0000269|PubMed:25629079"
FT                   /id="VAR_082620"
FT   VARIANT         364
FT                   /note="P -> R (in DEE75; unknown pathological significance;
FT                   dbSNP:rs35201073)"
FT                   /evidence="ECO:0000269|PubMed:29410512"
FT                   /id="VAR_082621"
SQ   SEQUENCE   475 AA;  53263 MW;  E3B1B07CB6225BA2 CRC64;
     MEGLLTRCRA LPALATCSRQ LSGYVPCRFH HCAPRRGRRL LLSRVFQPQN LREDRVLSLQ
     DKSDDLTCKS QRLMLQVGLI YPASPGCYHL LPYTVRAMEK LVRVIDQEMQ AIGGQKVNMP
     SLSPAELWQA TNRWDLMGKE LLRLRDRHGK EYCLGPTHEE AITALIASQK KLSYKQLPFL
     LYQVTRKFRD EPRPRFGLLR GREFYMKDMY TFDSSPEAAQ QTYSLVCDAY CSLFNKLGLP
     FVKVQADVGT IGGTVSHEFQ LPVDIGEDRL AICPRCSFSA NMETLDLSQM NCPACQGPLT
     KTKGIEVGHT FYLGTKYSSI FNAQFTNVCG KPTLAEMGCY GLGVTRILAA AIEVLSTEDC
     VRWPSLLAPY QACLIPPKKG SKEQAASELI GQLYDHITEA VPQLHGEVLL DDRTHLTIGN
     RLKDANKFGY PFVIIAGKRA LEDPAHFEVW CQNTGEVAFL TKDGVMDLLT PVQTV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024